sulfadoxine has been researched along with mefloquine in 202 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 67 (33.17) | 18.7374 |
| 1990's | 59 (29.21) | 18.2507 |
| 2000's | 38 (18.81) | 29.6817 |
| 2010's | 34 (16.83) | 24.3611 |
| 2020's | 4 (1.98) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
| Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
| Bunnag, D; Chindanond, D; Chittamas, S; Fernex, M; Harinasuta, T; Kristiansen, S; Malikul, S; Mittelholzer, ML; Sturchler, D | 1 |
| Adio, RA; Dickschat, U; Mittelholzer, ML; Reber-Liske, R; Salako, LA; Sowunmi, A; Stürchler, D; Walker, O | 1 |
| Bunnag, D; Chitamas, S; Harinasuta, T; Karbwang, J; Viravan, C | 1 |
| Reisinger, EC | 1 |
| Salako, LA; Sowunmi, A | 1 |
| Chongsuphajaisiddhi, T; Edstein, M; Luxemburger, C; Nosten, F; Phaipun, L; ter Kuile, F; Thew, KL; Webster, HK; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Frejacques, L; Luxemburger, C; Nosten, F; ter Kuiile, F; White, NJ | 1 |
| Bergqvist, Y; Eckerbom, S; Larsson, H; Malekzadeh, M | 1 |
| Trigg, PI | 1 |
| Carme, B | 1 |
| Baird, JK; Bangs, MJ; Basri, H; Jones, TR; Ritonga, A | 1 |
| Denis, MB; Giboda, M; Kouznetsov, RL | 1 |
| Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
| Holdener, F; Nurminen, L; Steffen, R; Wyss, R | 1 |
| Chongsuphajaisiddhi, T; Edstein, MD; Lika, ID; Sabchareon, A; Webster, HK | 1 |
| Malikul, S; Pinichpongse, S; Rooney, W; Tansophalaks, S; Thimasarn, K | 1 |
| Hopfenmüller, W; Janitschke, K; Schultes, U; Weber, G; Weinke, T | 1 |
| Hall, AP; Malin, AS | 1 |
| Eberlé, F; Gazin, P; Gelas, H; Hengy, C; Jambou, R; Kouka-Bemba, D | 1 |
| Brandicourt, O; Carme, B; Gay, F; Gentilini, M; Le Bras, J; Mbitsi, A; Moudzeo, H; Ndounga, M; Sathounkazi, C | 1 |
| Karbwang, J; White, NJ | 1 |
| Back, DJ; Breckenridge, AM; Bunnag, D; Karbwang, J | 2 |
| Arnold, K; Fu, LC; Guo, XB; Li, GQ; Liu, QD; Wang, NS | 1 |
| Cappelletti, G; Guenzi, A; Scala, A; Zanetti, M | 1 |
| Charmot, G; Coulaud, JP; Le Bras, J; Randriamanjaka, JR | 1 |
| Prociv, P | 1 |
| Bhisutthibhand, J; Brockelman, CR; Thanomsub, B | 1 |
| Hussein, S; Jamaludin, A; Kumar, A; Mansor, SM; Mohamad, M; Navaratnam, V; Wernsdorfer, WH | 1 |
| Aina Adio, R; Fadeke Aderounmu, A; Laoye, AJ; Modupe Makinde, J; Salako, LA | 1 |
| Newbold, CI; Pasvol, G; Peto, TE | 1 |
| Arnold, K | 2 |
| Bunnag, D; Harinasuta, T; Lasserre, R; Leimer, R; Vinijanont, S | 1 |
| Lwin, TT; Thwe, Y; Win, K | 1 |
| Campbell, JR; Dimpudus, AJ; Harun, S; Heizmann, P; Hoffman, SL; Marwoto, HA; Oetomo, HS; Punjabi, NH; Rustama, D; Sukri, N | 1 |
| Fernex, M; Heizmann, P; Leimer, R; Reber-Liske, R; Stohler, H | 1 |
| White, NJ | 1 |
| Kollaritsch, H; Kollaritsch, R; Kremsner, P; Leimer, R; Mailer, H; Stemberger, H; Wiedermann, G | 1 |
| Hlaing, N; Lasserre, R; Tin, F; Tun, T; Win, S | 1 |
| Kharazmi, A; Nielsen, H | 1 |
| Brubaker, G; Draper, CC; Hills, M; Kilimali, VA | 1 |
| Druilhe, P; Gentilini, M; Stahel, E | 1 |
| Fernex, M | 2 |
| Beeching, NJ; Eales, M; Ellis-Pegler, RB; Fraser, AG; Wells, AU | 1 |
| Aderounmu, AF; Adio, RA; Laoye, JO; Makinde, JM; Salako, LA | 1 |
| Arnold, K; Chen, PQ; Fu, LC; Guo, XB; Li, GQ | 1 |
| Rolfe, M | 1 |
| Asthana, OP; Nityanand, S; Tangri, AN | 1 |
| Bajpai, R; Dutta, GP; Shukla, B | 1 |
| Burchard, GD; Winkler, E | 1 |
| de Souza, JM; Doberstyn, EB; Sheth, UK; Trigg, PI; Wernsdorfer, WH | 1 |
| Bunnag, D; Charoenlarp, P; Chitamas, S; Harinasuta, T; Sheth, UK; Suntharasmai, P; Vanijanond, S; Wernsdorfer, WH | 1 |
| Ekue, JM; Mukunyandela, M; Phiri, DE; Sheth, UK | 1 |
| Myint, PT; Shwe, T | 1 |
| Charmot, G; Le Bras, J; Simon, F | 1 |
| Delmas, G; Hausler, B; Imvithaya, S; Lebihan, G; Nosten, F; Vincenti, M; White, N | 1 |
| Lasserre, R; Lim, MA; Tin, F; Win, S | 1 |
| Heizmann, P; Mimica, I; Portmann, R; Schwartz, DE; Weidekamm, E | 1 |
| Dubach, VC; Forgo, I; Ranalder, VB; Schwartz, DE; Weber, B; Weidekamm, E | 1 |
| Doberstyn, EB; Gaüzère, BA; Meek, SR; Nordlander, E; Phuphaisan, S; Thanapanich, C | 1 |
| Armstead, A; Campbell, CC; Collins, WE; Milhous, WK; Roberts, JM | 1 |
| Bhattacharya, DN; Hall, AP | 1 |
| Back, DJ; Karbwang, J; Looareesuwan, S; Molyneux, ME; Nagachinta, B; Phillips, RE; Warrell, DA; Wattanagoon, Y | 1 |
| Dubach, UC; Schwartz, DE; Weber, B; Weidekamm, E | 1 |
| Danis, M; Félix, H; Rosenheim, M | 1 |
| Glasner, H; Landscheidt, H; Niklewski, G | 1 |
| Peters, W | 1 |
| Ekue, JM; Njelesani, EK; Sheth, UK; Simooya, OO; Wernsdorfer, WH | 1 |
| Arias, AE; Cortes, GT; Espinal, CA; Guerra, P | 1 |
| de Oliveira, RM; de Souza, JM; de Souza, SD; Roulet, H; Sheth, UK | 1 |
| Cavalcante, EQ; de Oliveira, RM; de Souza, JM; Gomes, AT; Sheth, UK | 1 |
| Botero, D; Montoya, A; Restrepo, M | 1 |
| Danis, M; Gentilini, M | 1 |
| Salako, LA | 1 |
| Warhurst, DC | 1 |
| Arnold, K; Fu, LC; Guo, XB; Jian, HX; Li, GQ | 1 |
| de Souza, JM | 2 |
| Prüfer, L; von Sonnenburg, F | 1 |
| Ferraroni, JJ; Genaro, O | 1 |
| Peters, W; Robinson, BL | 1 |
| Brockelman, CR; Menabandhu, C; Tan-Ariya, P | 1 |
| Dixon, KE; Phintuyothin, P; Pitaktong, U; Pongsupat, T; Williams, RG | 1 |
| Ranalder, UB; Schwartz, DE | 1 |
| Timm, U; Weidekamm, E | 1 |
| Merkli, B; Peters, W; Richle, R | 1 |
| Canfield, CJ; Doberstyn, EB; Kennedy, RS; Pearlman, EJ; Sudsok, S; Thiemanun, W | 1 |
| Alvar, J; Amela, C; Benito, A; Molina, R; Roche, J | 1 |
| Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 1 |
| Deacon, HE; Freese, JA; Sharp, BL | 1 |
| Duong, TH; Igwangou, P; Kombila, M; Ngou-Milama, E; Ozouaki, P | 1 |
| Chatnugrob, P; Eamsila, C; Lasserre, R; Mittelholzer, ML; Nopavong Na Ayuthya, A; Singharaj, P; Stürchler, D; Webster, HK; Yooyen, P | 1 |
| Yang, H; Yang, P; Yang, Y | 1 |
| Edwards, G; Ward, SA; Winstanley, PA | 1 |
| Aouba, A; Guiguemde, TR; Lamizana, L; Ouedraogo, JB | 1 |
| Fuchs, E; Funk, M; Naef, U; Nevill, C; Phillips-Howard, P; Schildknecht, J; Schlagenhauf, P; Steffen, R; Stürchler, D | 1 |
| Bangchang, KN; Bunnag, D; Harinasuta, T; Karbwang, J; Rooney, W; Thimasarn, K | 1 |
| Angel, VH; Friman, G; Hellgren, U; Mittelholzer, ML; Rombo, L; Stürchler, D | 1 |
| Banmairuroi, V; Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K | 1 |
| Bálint, GS | 1 |
| Mittelholzer, ML; Stürchler, D | 1 |
| Bergqvist, Y; Breyer, S; Burgmann, H; Feistauer, S; Feucht, M; Graninger, W; Hellgren, U; Uhl, F; Winkler, S | 1 |
| Schubarth, P | 1 |
| Batchelor, R; Burans, JP; Iriye, C; Lobel, HO; Longer, CF; Magill, AJ; Rozmajzl, P; Sharp, TW; Smoak, B; Thornton, SA; Wallace, MR | 1 |
| Laomiphol, A; Palananth, C; Rooney, W; Sirichaisinthop, J; Tansophalaks, S; Tháithong, S; Thamewat, U; Thimasarn, K; Vijaykadga, S; Yamokgul, P | 1 |
| Handschin, J; Kremsner, PG; Nkeyi, M; Philipps, J; Radloff, PD; Stürchler, D | 1 |
| Adak, T; Ansari, MA; Biswas, S; Devi, CU; Pillai, CR; Sharma, YD | 1 |
| Lege-Oguntoye, L; Ogunrinde, GO; Okoyeh, JN; Ugbode, RO | 1 |
| Alin, MH | 1 |
| Davis, TM; Martin, RB | 1 |
| Aung, H; Aung, S; Kyaw, MP; Lwin, M; Oo, H; Sint, N; Thein, H; Tun, SM; Win, Y | 1 |
| Kremsner, PG; Philipps, J; Radloff, PD; Wernsdorfer, W | 1 |
| Handschin, J; Kremsner, PG; Lehman, LG; Lell, B; Schmidt-Ott, JR; Sturchler, D | 1 |
| Coppel, RL; Marshall, VM; Tieqiao, W | 1 |
| Edwards, R; Fuchs, E; Kerr, L; Phillips-Howard, PA; Schildknecht, J; Steffen, R; Vanhauwere, B | 1 |
| Bourgeade, A; Delmont, J | 1 |
| Aung, S; Ejov, MN; Sein, K; Tun, T | 1 |
| Alaribe, AA; Chukwuani, CM; Ekanem, OJ; Ezedinachi, EN; Haller, L; Meremikwu, MM; Ojar, EA; Umotong, AB | 1 |
| Kremsner, PG; Kun, JF; Lehman, LG; Lell, B; Schmidt-Ott, R | 1 |
| Makonnen, E; Mengesha, T | 1 |
| Dalvi, SS; Gogtay, NJ; Kshirsagar, NA; Rajgor, D; Wakde, M | 1 |
| Saul, A | 1 |
| Bloland, PB; Ettling, M; Meek, S | 1 |
| Granier, H; Laborde, JP; Martin, J; Nicolas, X; Talarmin, F | 1 |
| Ali, D; Barat, LM; Green, MD; Kazembe, PN; Kolczak, MS; MacArthur, J; Macheso, A; Ruebush, TK; Stennies, GM | 1 |
| D'Acremont, V; Darioli, R; Genton, B; Landry, P; Pécoud, A; Stuerchler, D | 1 |
| Bedos, JP; Bruneel, F; Danis, M; Gachot, B; Regnier, B; Vachon, F; Wolff, M | 1 |
| Arróspide, N; Arrunátegui, M; Barat, LM; Cabezas, C; Carrillo, C; Chafloque, ML; Garavito, G; Gutierrez, S; MacArthur, JR; Marquiño, W; Oblitas, FE; Pardavé, B; Ruebush, TK | 1 |
| Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
| Nakajima, Y | 1 |
| Pfeifer, C; Strauss, R | 1 |
| Fateye, BA; Sowunmi, A | 1 |
| Akpede, GO; Ekanem, OJ; Molta, NB; Watila, IM | 1 |
| Fischer, PR; Stauffer, W | 1 |
| Hoshen, M | 1 |
| Hayton, K; Su, XZ | 1 |
| Majori, G | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Meshnick, SR; Prajakwong, S; Shanks, GD; Thimasarn, K; Wongsrichanalai, C | 1 |
| Baird, JK | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Kremsner, PG; Krishna, S; Lell, B; Ramharter, M; Uhlemann, AC | 1 |
| Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
| Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
| Faragalla, IA; Mohamadani, AA; Nour, BY; Saeed, OK | 1 |
| Shen, WJ; Thiero, M | 1 |
| Arayne, MS; Naseem, S; Qureshi, MS; Sultana, N | 1 |
| Congpuong, K; Na-Bangchang, K | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Bissagnene, E; Die-Kakou, H; Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJ | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Ayemonna, P; Bottero, J; Briand, V; Cordel, H; Cot, M; Fayomi, B; Fievet, N; Guerra, J; Kossou, H; Masse, V; Massougbodji, A; Noël, H | 1 |
| Cairns, M; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Mosha, J | 1 |
| Carneiro, I; Chandramohan, D; Gesase, S; Gosling, RD; Greenwood, B; Hashim, R; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
| Cairns, M; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Hashim, R; Kaur, H; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
| Capan, M; Makristathis, A; Mombo-Ngoma, G; Ramharter, M | 1 |
| Bouraima, A; Briand, V; Choudat, I; Cot, M; Cottrell, G; Dechavanne, C; Fayomi, B; Garcia, A; Guerra, J; Le Port, A; Massougbodji, A; Migot-Nabias, F | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Chandramohan, D; Chico, RM | 1 |
| Bertin, G; Bonaventure, D; Briand, V; Carrieu, A; Cot, M; Deloron, P; Massougbodji, A | 1 |
| Ensom, MH; Wilby, KJ | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
| Borgella, S; Briand, V; Cot, M; Deloron, P; Fievet, N; Huynh, BT; Massougbodji, A | 1 |
| Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Bin Dajem, SM | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Adegnika, AA; Basra, A; Diop, DA; Fürstenau, M; Gonzalez, R; Kremsner, PG; Mackanga, JR; Melser, MC; Menendez, C; Mombo-Ngoma, G; Ramharter, M; Würbel, H; Zoleko, RM | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
| Mannemala, SS; Nagarajan, JS | 1 |
| Adegnika, AA; Agnandji, ST; Akerey-Diop, D; Basra, A; Bélard, S; Capan-Melser, M; González, R; Groger, M; Kremsner, PG; Lötsch, F; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo Ngoma, G; Ramharter, M; Rehman, K; Schipulle, U; Schwing, J; Würbel, H; Zoleko-Manego, R | 1 |
| Abdulla, S; Aponte, J; Cot, M; Desai, M; Fernandes, S; González, R; Hanson, K; Katana, A; Kremsner, P; Kuwawenaruwa, A; Macete, E; Massougbodgi, A; Menéndez, C; Mombo-Ngoma, G; Ramharter, M; Sicuri, E; Slustker, L | 1 |
| Baker, M; Marquart, L; McCarthy, JS; O'Rourke, P | 1 |
| Briand, V; Cot, M; Escolano, S; Journot, V; Massougbodji, A; Tubert-Bitter, P | 1 |
| Alifrangis, M; Baraka, V; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Hashim, R; Ishengoma, D; Mosha, J; Poirot, E; Vittinghoff, E | 1 |
| Abdulla, S; Accrombessi, M; Adegnika, AA; Aponte, JJ; Briand, V; Cot, M; González, R; Kabanywanyi, AM; Kakolwa, MA; Kremsner, PG; Macete, E; Manego Zoleko, R; Massougbodji, A; Menéndez, C; Mombo-Ngoma, G; Ouédraogo, S; Ramharter, M; Rupérez, M; Sevene, E; Vala, A | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| Lee, SJ; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO | 1 |
| Duffy, PE; Fried, M | 1 |
| Choi, L; Garner, P; Gelband, H; Graves, PM | 1 |
| Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO | 2 |
| Abdus-Salam, R; Akinyotu, O; Arowojolu, A; Bello, F | 1 |
| Anvikar, AR; Arya, T; Bruce, J; Chandramohan, D; Greenwood, B; Kuepfer, I; Mishra, DR; Mishra, N; Mishra, V; Mohanty, R; Mohanty, S; Sharma, S; Srivastava, B; Valecha, N | 1 |
| Akerey-Diop, D; Basra, A; Geditz, M; Gonzalez, R; Hofmann, U; Kerb, R; Kremsner, PG; Lehr, T; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo-Ngoma, G; Ramharter, M; Schwab, M; Wojtyniak, JG; Würbel, H; Zoleko Manego, R | 1 |
| Aponte, JJ; Cisteró, P; Cot, M; Desai, M; González, R; Gupta, H; Huijben, S; Kariuki, S; Macete, E; Massougbodji, A; Mayor, A; Menéndez, C; Mombo-Ngoma, G; Mwangoka, G; Ndam, NT; Ramharter, M; Shi, YP; Uberegui, E | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E | 1 |
34 review(s) available for sulfadoxine and mefloquine
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Clinical pharmacokinetics of mefloquine.
Topics: Animals; Antimalarials; Drug Combinations; Drug Interactions; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1990 |
[Malaria in Switzerland].
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Switzerland | 1988 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Half-Life; Humans; Kinetics; Male; Mefloquine; Mice; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine; Sulfalene | 1985 |
New drugs and their potential use against drug-resistant malaria.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Mice; Naphthoquinones; Plasmodium falciparum; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
[Progress in immunodiagnosis and chemotherapy of protozoan infections].
Topics: Amebiasis; Animals; Antibodies; Babesiosis; Chloroquine; Drug Resistance, Microbial; Giardiasis; Humans; Leishmaniasis; Malaria; Mefloquine; Pneumocystis; Pneumonia, Pneumocystis; Primaquine; Protozoan Infections; Pyrimethamine; Quinine; Quinolines; Serologic Tests; Sulfadoxine; Tetracycline; Toxoplasmosis; Trypanosomiasis | 1983 |
[Urgent need for new antimalarias (author's transl)].
Topics: Antimalarials; Biological Availability; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Immunotherapy; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine; World Health Organization | 1981 |
Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.
Topics: Chloroquine; Diethylcarbamazine; Drug Resistance; Echinococcosis; Filariasis; Humans; Malaria; Mefloquine; Pharmacokinetics; Phenanthrenes; Pyrimethamine; Quinine; Sulfadoxine; Tropical Medicine | 1994 |
[Malaria: the most important emergency in subjects returning from the tropics].
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Emergencies; Humans; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium; Pyrimethamine; Quinidine; Quinine; Sulfadoxine | 1993 |
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Topics: Africa, Eastern; Africa, Western; Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Costs; Humans; Malaria; Mefloquine; Patient Selection; Phenanthrenes; Pyrimethamine; Quinine; Safety; Sulfadoxine; Treatment Outcome | 1999 |
Combination therapy for malaria in Africa: hype or hope?
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Cross-Cultural Comparison; Half-Life; Humans; Insecticide Resistance; Malaria; Mefloquine; Pyrimethamine; Self Medication; Sesquiterpenes; Sulfadoxine; Thailand | 2000 |
[Antiprotozoal drugs].
Topics: Animals; Antiprotozoal Agents; Drug Combinations; Emetine; Humans; Mefloquine; Metronidazole; Phenanthrenes; Primaquine; Protozoan Infections; Pyrimethamine; Quinine; Sulfadoxine; Tinidazole | 2003 |
Genetic and biochemical aspects of drug resistance in malaria parasites.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Resistance; Drug Resistance, Multiple; Humans; Linkage Disequilibrium; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Effectiveness of antimalarial drugs.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Life Cycle Stages; Malaria; Mefloquine; Patient Compliance; Plasmodium; Primaquine; Pyrimethamine; Quinine; Secondary Prevention; Sulfadoxine; Treatment Failure | 2005 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand.
Topics: Age Factors; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium; Quinine; Sesquiterpenes; Sex Factors; Sulfadoxine | 2007 |
Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria; Mefloquine; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Topics: Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimalarials; Azithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Public Health; Pyrimethamine; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome | 2011 |
Pharmacokinetics of antimalarials in pregnancy: a systematic review.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Malaria during Pregnancy.
Topics: Africa; Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria Vaccines; Mefloquine; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine | 2017 |
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Topics: Adult; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Non-Randomized Controlled Trials as Topic; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine; Time Factors | 2018 |
Mefloquine for preventing malaria in pregnant women.
Topics: Abortion, Spontaneous; Africa South of the Sahara; Antimalarials; Dizziness; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Low Birth Weight; Insecticide-Treated Bednets; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Thailand; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Malaria; Mefloquine; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Stillbirth; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.
Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations | 2021 |
70 trial(s) available for sulfadoxine and mefloquine
| Article | Year |
|---|---|
Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1992 |
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1992 |
Clinical trials of mefloquine with tetracycline.
Topics: Acute Disease; Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetracycline | 1992 |
[Self-medication of 193 travelers in the tropics. Recommendations for clinical counseling of tropical travelers and organization of a tropical travel pharmacy].
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nonprescription Drugs; Pharmaceutical Services; Prospective Studies; Pyrimethamine; Self Medication; Sulfadoxine; Travel; Tropical Medicine | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Mefloquine-resistant falciparum malaria on the Thai-Burmese border.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Humans; Incidence; Malaria; Male; Mefloquine; Myanmar; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Recurrence; Refugees; Sulfadoxine; Thailand; Vomiting | 1991 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
Topics: Adult; Animals; Antimalarials; Double-Blind Method; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1990 |
Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet.
Topics: Administration, Oral; Adult; Asian People; Biological Availability; China; Drug Compounding; Drug Resistance; Drug Therapy, Combination; Half-Life; Humans; Male; Mefloquine; Metabolic Clearance Rate; Pyrimethamine; Random Allocation; Sulfadoxine; Sulfanilamides; Time Factors | 1990 |
Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Topics: Animals; Antimalarials; Child; Chloroquine; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Topics: Adolescent; Adult; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Topics: Adolescent; Adult; Antimalarials; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Topics: Adolescent; Adult; Antimalarials; Child; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Topics: Adolescent; Adult; Animals; Antimalarials; Aspartate Aminotransferases; Blood Cell Count; Child; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Humans; Malaria; Male; Mefloquine; Middle Aged; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
Clinical trial of fansimef in Indian patients of P. falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Clinical Trials as Topic; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1988 |
A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Brazil; Double-Blind Method; Drug Combinations; Drug Evaluation; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1987 |
Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Double-Blind Method; Drug Combinations; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides; Thailand | 1987 |
A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Child; Double-Blind Method; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1987 |
The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Topics: Adult; Animals; Antimalarials; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Quinine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
The use of immunofluorescence to evaluate the efficacy of malarial chemoprophylaxis.
Topics: Adolescent; Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Fluorescent Antibody Technique; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine | 1987 |
Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine | 1987 |
Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.
Topics: Cambodia; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinine; Quinolines; Sulfadoxine; Sulfanilamides; Tetracycline; Thailand | 1986 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides; Zambia | 1985 |
An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
Topics: Adolescent; Adult; Brazil; Clinical Trials as Topic; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
Topics: Adult; Brazil; Double-Blind Method; Drug Combinations; Drug Evaluation; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Clinical Trials as Topic; Colombia; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; China; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Quinolines; Random Allocation; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1984 |
A phase I clinical trial of mefloquine in Brazilian male subjects.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine | 1983 |
A phase II clinical trial of mefloquine in Brazilian male subjects.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine | 1983 |
A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Topics: Antimalarials; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1982 |
Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
Topics: Adolescent; Adult; Antimalarials; Child; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Piperidines; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sulfadoxine; Thailand | 1980 |
Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
Topics: Adult; Animals; Antibodies, Protozoan; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1993 |
Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Combinations; Half-Life; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Dropouts; Pyrimethamine; Sulfadoxine | 1993 |
Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1993 |
In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
Topics: Adult; Animals; Antimalarials; Cambodia; Chi-Square Distribution; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mining; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand; Transients and Migrants | 1995 |
Responses of multidrug-resistant Plasmodium falciparum parasites to mefloquine in Nigerian children.
Topics: Animals; Anti-Infective Agents; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Microbial Sensitivity Tests; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1997 |
Clearance of young parasite forms following treatment of falciparum malaria in humans: comparison of three simple mathematical models.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Kinetics; Lactones; Linear Models; Malaria, Falciparum; Mefloquine; Middle Aged; Models, Biological; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1997 |
Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 1998 |
Response of falciparum malaria to different antimalarials in Myanmar.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine | 1999 |
Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.
Topics: Africa; Animals; Antimalarials; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
Topics: Animals; Antimalarials; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
Topics: Adolescent; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Gabon; Genes, MDR; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
[Coartem and fansimef in the treatment of falciparum malaria].
Topics: Abdominal Pain; Adolescent; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fever; Fluorenes; Humans; Malaria, Falciparum; Male; Mali; Mefloquine; Nausea; Pyrimethamine; Skin; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Single-Blind Method; Stillbirth; Sulfadoxine; Young Adult | 2009 |
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Dapsone; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Half-Life; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Logistic Models; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Proguanil; Pyrimethamine; Safety; Sulfadoxine; Tanzania; Treatment Outcome | 2009 |
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
Topics: Antimalarials; Dapsone; Drug Administration Schedule; Drug Combinations; Drug Resistance; Humans; Immunization Schedule; Infant; Infant, Newborn; Malaria; Mefloquine; Pediatrics; Placebos; Proguanil; Pyrimethamine; Research Design; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
Topics: Adult; Antimalarials; Benin; Chloroquine; Drug Combinations; Female; Health Policy; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Maternal Age; Mefloquine; Multivariate Analysis; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2011 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.
Topics: Adult; Animals; Anthelmintics; Chemoprevention; Drug Combinations; Feces; Female; Gabon; Humans; Mefloquine; Parasite Egg Count; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Schistosoma haematobium; Schistosomiasis haematobia; Single-Blind Method; Sulfadoxine; Treatment Outcome; Young Adult | 2013 |
Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Topics: Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female; HIV Infections; Humans; Kenya; Malaria; Mefloquine; Mozambique; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2015 |
Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.
Topics: Adolescent; Adult; Algorithms; Antimalarials; Area Under Curve; Drug Combinations; Female; Half-Life; Humans; Malaria; Male; Mefloquine; Models, Statistical; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Young Adult | 2015 |
Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
Topics: Anemia; Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; Mefloquine; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Stillbirth; Sulfadoxine; Treatment Outcome | 2015 |
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Topics: Antimalarials; Cohort Studies; Dapsone; Double-Blind Method; Drug Combinations; Female; Genotype; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Logistic Models; Malaria; Male; Mefloquine; Multivariate Analysis; Odds Ratio; Poisson Distribution; Polymorphism, Single Nucleotide; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 2015 |
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
Topics: Adult; Africa, Southern; Antimalarials; Child; Child Development; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Maternal Exposure; Mefloquine; Morbidity; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Pyrimethamine; Sulfadoxine; Survival Rate; Treatment Outcome | 2016 |
Comparative study of mefloquine and sulphadoxine-pyrimethamine for malaria prevention among pregnant women with HIV in southwest Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine | 2018 |
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Incidence; India; Intention to Treat Analysis; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2018 |
Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2020 |
99 other study(ies) available for sulfadoxine and mefloquine
| Article | Year |
|---|---|
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Mefloquine plus sulfadoxine and pyrimethamine.
Topics: Animals; Drug Combinations; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1991 |
Mefloquine for multidrug-resistant malaria.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Psychoses, Substance-Induced; Pyrimethamine; Refugees; Sulfadoxine | 1991 |
Reversed-phase liquid chromatographic method for the simultaneous determination of the antimalarial drugs sulfadoxine, pyrimethamine, mefloquine and its major carboxylic metabolite in plasma.
Topics: Antimalarials; Chromatography, High Pressure Liquid; Humans; Mefloquine; Pyrimethamine; Sulfadoxine | 1991 |
Drug use and design in the nineties.
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Calcium Channel Blockers; Chloroquine; Humans; Malaria; Mefloquine; Naphthoquinones; Phenanthrenes; Primaquine; Quinine; Sesquiterpenes; Sulfadoxine | 1991 |
[Prevention and treatment of malaria in expatriates living in Black Africa. Influence of chemoresistance. Investigations conducted in Brazzaville (Congo)].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance, Microbial; Europe; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
Topics: Animals; Cambodia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 1991 |
Malaria prophylaxis and self-therapy in airline crews.
Topics: Aerospace Medicine; Africa; Animals; Antimalarials; Culicidae; Drug Combinations; Drug Resistance; Emergencies; Humans; Incidence; Insect Bites and Stings; Malaria; Mefloquine; Patient Compliance; Protective Clothing; Pyrimethamine; Self Medication; Sulfadoxine | 1990 |
Quantitation of Fansimef components (mefloquine + sulfadoxine + pyrimethamine) in human plasma by two high-performance liquid chromatographic methods.
Topics: Antimalarials; Child; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 1991 |
Malaria prophylaxis in travellers to tropical Africa.
Topics: Africa; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1990 |
Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
Topics: Adult; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides | 1990 |
[Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1990 |
[Plasmodium falciparum drug resistance in the Congo. Evaluation of surveys carried out from 1985 to 1989].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1990 |
Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria.
Topics: Adolescent; Adult; Animals; Drug Resistance; Drug Therapy, Combination; Half-Life; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine | 1990 |
Simultaneous determination of pyrimethamine and mefloquine in human plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Mefloquine; Pyrimethamine; Spectrophotometry, Ultraviolet; Sulfadoxine | 1989 |
[Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Topics: Adult; Africa; Animals; Antimalarials; Drug Resistance; Drug Therapy, Combination; Female; France; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1989 |
Fansimef in the treatment of malaria.
Topics: Animals; Antimalarials; Drug Combinations; Humans; Malaria; Mefloquine; Plasmodium vivax; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1989 |
Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
Topics: Animals; Drug Resistance; Drug Therapy, Combination; Humans; Mefloquine; Parasitology; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Thailand; Time Factors | 1989 |
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
Topics: Adult; Drug Combinations; Drug Evaluation; Humans; Male; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1989 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Artemisinins; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1985 |
Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
Topics: Drug Resistance, Microbial; Humans; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1986 |
Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1986 |
Combination treatment for falciparum prophylaxis.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Topics: Adolescent; Adult; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
In vitro effect of fansimef on human neutrophil and monocyte function.
Topics: Blood Bactericidal Activity; Chemotaxis; Drug Combinations; Humans; In Vitro Techniques; Luminescent Measurements; Mefloquine; Monocytes; Neutrophils; Nitroblue Tetrazolium; Oxidation-Reduction; Phagocytosis; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides; Superoxides | 1986 |
Serial studies on the evolution of drug resistance in malaria in an area of east Africa: findings from 1979 up to 1986.
Topics: Age Factors; Amodiaquine; Animals; Antibodies, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Quinolines; Sulfadoxine; Tanzania | 1988 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Topics: Adolescent; Adult; Animals; Child; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
Selection of Plasmodium yoelii nigeriensis resistant to triple drug combination (sulphadoxine/pyrimethamine/mefloquine) and its response to other antimalarials.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Female; Male; Mefloquine; Mice; Plasmodium yoelii; Pyrimethamine; Quinolines; Sulfadoxine | 1988 |
Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
Topics: Animals; Chloroquine; Drug Combinations; Drug Resistance; Gabon; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
[2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.
Topics: Adult; Animals; Antimalarials; Child; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Thailand | 1987 |
Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
Topics: Adult; Antimalarials; Drug Combinations; Female; Half-Life; Humans; Kinetics; Male; Mefloquine; Metabolic Clearance Rate; Middle Aged; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.
Topics: Adult; Antimalarials; Biological Availability; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Mefloquine; Pyrimethamine; Quinolines; Sex Factors; Sulfadoxine; Sulfanilamides | 1987 |
Absence of pharmacokinetic interaction between Fansidar and mefloquine.
Topics: Antimalarials; Drug Combinations; Drug Interactions; Humans; Kinetics; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1986 |
Adaptation of the Indochina I/CDC strain of Plasmodium falciparum to the squirrel monkey (Saimiri sciureus).
Topics: Animals; Aotus trivirgatus; Cebidae; Chloroquine; Disease Models, Animal; Drug Resistance; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Saimiri; Splenectomy; Sulfadoxine | 1986 |
Chloroquine-resistant falciparum malaria from East Africa.
Topics: Adult; Africa, Eastern; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1986 |
Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
Topics: Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Intestinal Absorption; Kinetics; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
Topics: Adult; Antimalarials; Biological Availability; Blood Proteins; Drug Combinations; Drug Interactions; Erythrocytes; Half-Life; Humans; Kinetics; Male; Mefloquine; Middle Aged; Protein Binding; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
[Making good use of mefloquine].
Topics: Adult; Antimalarials; Child; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
[A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Meningoencephalitis; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
Topics: Amodiaquine; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance, Microbial; Geography; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
[Malaria chemoprophylaxis. Resistance problems].
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1985 |
[Malaria and intestinal parasitosis in Indians of the Nadeb-Maku tribe, State of Amazonas, Brazil].
Topics: Adolescent; Adult; Antimalarials; Brazil; Child; Child, Preschool; Drug Combinations; Feces; Female; Humans; Indians, South American; Intestinal Diseases, Parasitic; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1984 |
The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides; Time Factors | 1984 |
Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance, Microbial; Mefloquine; Plasmodium falciparum; Quinolines; Sulfadoxine; Sulfanilamides | 1984 |
Highly sensitive and specific determination of mefloquine in biological fluids using gas chromatography mass spectrometry with selected ion monitoring.
Topics: Drug Combinations; Gas Chromatography-Mass Spectrometry; Humans; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine | 1981 |
Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
Topics: Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Drug Therapy, Combination; Fluorescence; Half-Life; Humans; Kinetics; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1982 |
The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Erythrocytes; Male; Mefloquine; Mice; Piperidines; Plasmodium berghei; Pyrimethamine; Quinolines; Sulfadoxine | 1980 |
In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Equatorial Guinea; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
Prevention of malaria in travellers from the United Kingdom.
Topics: Adult; Antimalarials; Developing Countries; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Pyrimethamine; Quinine; Sulfadoxine; Travel; United Kingdom | 1993 |
Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
[Variation of cholostase enzymes (5'-nucleotidase and alkaline phosphatase) during a specific treatment for malaria in the Gabonese child].
Topics: 5'-Nucleotidase; Alkaline Phosphatase; Antimalarials; Child; Child, Preschool; Drug Combinations; Gabon; Humans; Infant; Malaria; Mefloquine; Phenanthrenes; Pyrimethamine; Reference Values; Sulfadoxine | 1995 |
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991).
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Chloroquine; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Pyrimethamine; Quinine; Retrospective Studies; Sulfadoxine | 1994 |
Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
Topics: Adult; Antimalarials; Chloroquine; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1993 |
Mefloquine level monitoring in patients with multidrug resistant Plasmodium falciparum on the Thai Myanmar border.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Cambodia; Chromatography, High Pressure Liquid; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Pyrimethamine; Sulfadoxine; Thailand; Treatment Outcome | 1993 |
[Current possibilities of malaria chemoprophylaxis].
Topics: Africa; Animals; Antimalarials; Contraindications; Developing Countries; Drug Combinations; Humans; Hungary; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1994 |
[Emergency treatment of malaria during travel].
Topics: Antimalarials; Drug Combinations; Emergencies; Humans; Malaria; Mefloquine; Patient Education as Topic; Pyrimethamine; Sulfadoxine; Travel | 1993 |
[Mefloquine and sulfadoxine/pyrimethamine overdose in malaria tropica].
Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Pyrimethamine; Sulfadoxine; Thioridazine | 1993 |
Malaria among United States troops in Somalia.
Topics: Anti-Bacterial Agents; Antimalarials; Chemoprevention; Chloroquine; Clothing; Cohort Studies; Doxycycline; Drug Resistance; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Population Surveillance; Prospective Studies; Protective Devices; Pyrimethamine; Quinine; Risk Factors; Somalia; Sulfadoxine; Treatment Failure; Treatment Refusal; United States | 1996 |
Minimal effective dose of mefloquine/sulfadoxine/pyrimethamine in mild Plasmodium falciparum malaria.
Topics: Adolescent; Antimalarials; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Pilot Projects; Pyrimethamine; Sulfadoxine | 1995 |
High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Chloroquine; Disease Outbreaks; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; India; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Seroepidemiologic Studies; Sulfadoxine; Tumor Necrosis Factor-alpha | 1996 |
In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Humans; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania | 1997 |
A simplified in vivo drug sensitivity test for malaria in the field.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 1997 |
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Follow-Up Studies; Gabon; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes; Sulfadoxine | 1998 |
Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum.
Topics: Amino Acid Sequence; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Base Sequence; Chromosomes; DNA, Complementary; DNA, Protozoan; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique, Indirect; Genes, Protozoan; Immunoblotting; Mefloquine; Membrane Proteins; Molecular Sequence Data; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Rabbits; Sulfadoxine | 1998 |
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Chloroquine; Databases, Factual; Drug Combinations; Drug Industry; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Proguanil; Prospective Studies; Pyrimethamine; Risk Factors; Safety; Sulfadoxine; Surveys and Questionnaires | 1998 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Blood; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nigeria; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Random Allocation; Sulfadoxine | 1999 |
An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; India; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2000 |
[Danger of malaria self-treatment. Acute neurologic toxicity of mefloquine and its combination with pyrimethamine-sulfadoxine].
Topics: Adult; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Pyrimethamine; Self Medication; Sulfadoxine | 2001 |
Treatment of imported malaria in an ambulatory setting: prospective study.
Topics: Adolescent; Adult; Africa; Aged; Ambulatory Care; Antimalarials; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Outpatient Clinics, Hospital; Prospective Studies; Pyrimethamine; Sulfadoxine; Switzerland; Travel | 2002 |
[Blackwater fever].
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Blackwater Fever; Critical Care; Diagnosis, Differential; Drug Combinations; Humans; Mefloquine; Middle Aged; Naphthoquinones; Phenanthrenes; Prognosis; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2002 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2003 |
Preliminary assessment of the efficacy of mefloquine/-sulphadoxine/ pyrimethamine combination in the treatment of uncomplicated malaria in children in North Eastern Nigeria.
Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Mefloquine; Nigeria; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Artesunate combinations for malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2004 |
Mefloquine--its 20 years in the Thai Malaria Control Program.
Topics: Animals; Antimalarials; Communicable Disease Control; Contraindications; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Sulfadoxine; Thailand | 2004 |
In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
Topics: Animals; Antimalarials; Chloroquine; In Vitro Techniques; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Sudan; Sulfadoxine | 2006 |
Interaction studies of omeprazole with mefloquine, pyrimethamine and sulfadoxine.
Topics: Antimalarials; Drug Interactions; Hydrogen-Ion Concentration; Mefloquine; Omeprazole; Pyrimethamine; Solubility; Sulfadoxine; Thermodynamics | 2006 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.
Topics: Amodiaquine; Antimalarials; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 2009 |
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Bacterial Infections; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2010 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Development and validation of a generic liquid chromatographic method for the simultaneous determination of five commonly used antimalarial drugs: Application to pharmaceutical formulations and human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Healthy Volunteers; Humans; Lumefantrine; Mefloquine; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Tablets | 2015 |
Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Drug Combinations; Female; Gabon; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Rectum; Streptococcal Infections; Streptococcus agalactiae; Sulfadoxine; Vagina; Young Adult | 2015 |
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Topics: Adolescent; Adult; Anorexia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Host-Parasite Interactions; Humans; Malaria; Male; Mefloquine; Nausea; Outcome Assessment, Health Care; Plasmodium falciparum; Plasmodium vivax; Psychotic Disorders; Pyrimethamine; Sulfadoxine; Thailand; Vomiting; Young Adult | 2017 |
Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Humans; Malaria; Mefloquine; Pharmacokinetics; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |